ESR2 and malignant mesothelioma: In cancers, such as malignant mesothelioma [62], ERβ appears to be proapoptotic thus enabling it to destroy malignant cells whilst ERα has antiapoptotic activity which underpins its role in normal and abnormal cell proliferation.